Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down – Here’s Why

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares gapped down before the market opened on Monday . The stock had previously closed at $312.75, but opened at $291.36. Bio-Rad Laboratories shares last traded at $291.36, with a volume of 67 shares.

Bio-Rad Laboratories Stock Performance

The firm’s 50 day moving average is $311.24 and its 200-day moving average is $287.51. The firm has a market cap of $7.96 billion, a price-to-earnings ratio of -12.14 and a beta of 1.01. The company has a debt-to-equity ratio of 0.18, a quick ratio of 3.94 and a current ratio of 5.44.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.